(Q42262404)

English

Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis

scientific article published on May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 October 2017

Treatment with anti–tumor necrosis factor biologic agents in human T lymphotropic virus type I–positive patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

19 October 2017

Human T-lymphotropic virus 1

0 references

author name string

Kunihiko Umekita

1

1 reference

Europe PubMed Central

19 October 2017

Toshihiko Hidaka

2

1 reference

Europe PubMed Central

19 October 2017

Shunichi Miyauchi

3

1 reference

Europe PubMed Central

19 October 2017

Shiro Ueno

4

1 reference

Europe PubMed Central

19 October 2017

Kazuyoshi Kubo

5

1 reference

Europe PubMed Central

19 October 2017

Ichiro Takajo

6

1 reference

Europe PubMed Central

19 October 2017

Yayoi Hashiba

7

1 reference

Europe PubMed Central

19 October 2017

Yasufumi Kai

8

1 reference

Europe PubMed Central

19 October 2017

Yasuhiro Nagatomo

9

1 reference

Europe PubMed Central

19 October 2017

Akihiko Okayama

10

1 reference

Europe PubMed Central

19 October 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2014

1 reference

Europe PubMed Central

19 October 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

19 October 2017

66

1 reference

Europe PubMed Central

19 October 2017

5

1 reference

Europe PubMed Central

19 October 2017

788-792

1 reference

Europe PubMed Central

19 October 2017

The efficacy of biologic agents in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors: a systematic review.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

HTLV-1-associated diseases

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Human T lymphotropic virus type I in arthropathy and autoimmune disorders

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

High seroprevalence of anti-HTLV-I antibody in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Arthritis in patients infected with human T lymphotropic virus type I. Clinical and immunopathologic features

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Use of anti-tumor necrosis factor biologics in the treatment of rheumatoid arthritis does not change human T-lymphotropic virus type 1 markers: a case series

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Altered expression of inflammatory cytokines in primary osteoarthritis by human T lymphotropic virus type I retrovirus infection: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Continuation of Methotrexate Resulted in Better Clinical and Radiographic Outcomes Than Discontinuation upon Starting Etanercept in Patients with Rheumatoid Arthritis: 52-week Results from the JESMR Study

1 reference

https://api.crossref.org/works/10.1002%2FACR.22205

21 January 2018

Identifiers

10.1002/ACR.22205

1 reference

Europe PubMed Central

19 October 2017

release_y4iobphilvfkzkkfbj6vykp2tu

1 reference

https://api.fatcat.wiki/v0/release/y4iobphilvfkzkkfbj6vykp2tu

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42262404&oldid=1940408212"